(571) 447-5500

EAS Blog

EAS Independent Consultants and staff provide in-depth regulatory expertise and authoritative reporting on a variety of compliance requirements for industries that EAS serves. Our experts break down complicated topics into easily understandable summaries and analysis. Subscribe to our newsletter and receive these monthly updates directly in your in-box.

“Tree Nut” Allergy; Is It a Misnomer?

“Tree Nut” Allergy; Is It a Misnomer?

By Lisa Zitiello, EAS Consulting Group, Independent ConsultantFood safety professionals across the globe will agree that one key safety factor in food production today is the avoidance of allergen cross-contact. This is closely followed by declaring an allergen ingredient on the finished product...

read more
Drug and Device August 2023

Drug and Device August 2023

We will be entering the establishment renewal and product listing certification period soon. As your regulatory support partner, EAS is here for any questions you may have.  If you wish for us to handle the annual requirements, please email Victoria Pankovich to get on the schedule. The annual...

read more
Beverage Manufacturing

Beverage Manufacturing

What’s Hot in the Beverage Industry? A look at trends and regulations for beverage manufacturingSeptember 12, 2023 at 1 p.m. EasternPresented by Omar Oyarzabal, Ph.D., EAS Consulting Group and Alex Brandt, Ph.D. Certified GroupThe beverage industry is thriving. From sports recovery to hydration,...

read more
Drug and Device July 2023

Drug and Device July 2023

Thinking about an FDA gap assessment this year? Contact EAS now to schedule your 2023 audit. Schedules toward the end of the year tend to book up suddenly, now is the time to lock in your audit, whether it be onsite or virtual. We would be happy to prepare an audit proposal so you can review and...

read more
Biofilms and Healthcare

Biofilms and Healthcare

By David W Koenig, PhD., EAS Consulting Group Independent ConsultantHealthcare facilities -- such as hospitals, nursing homes and outpatient facilities -- are opportunistic locations for acquiring secondary infections unrelated to a patient's primary condition. Healthcare-acquired infections...

read more
Drug and Device June 2023

Drug and Device June 2023

The FDA has published a new Guidance Document Assessing User Fees Under the Generic Drug User Fee Amendments of 2022 which explains in great detail the GDUFA program user fee obligations. GDUFA III made slight changes to the user fee structure. (API facility fees changed from 7% to 6% and the...

read more
The Food Safety Language

The Food Safety Language

By Rafael Olivares, EAS Independent ConsultantA career in food safety is not an easy one. It is a stressful profession that requires dedication and a commitment to learn continuously and to teach, to communicate effectively to an audience, in most cases, obstinate, and not open to listen. After...

read more
Drug and Device May 2023

Drug and Device May 2023

As we approach June, keep in mind that drug establishment registrations and NDC listings that have had any changes to their information must update their files with the FDA within 30 days. Failing that, the agency expects updates to be submitted the JUNE or December following such a change. Do...

read more
Claims Substantiation Seminar

Claims Substantiation Seminar

Presented by Paula Brock, PhD., EAS Senior Regulatory ConsultantMarch 14, 2024 1:00 – 3:00PM (Eastern)It is required in the United States that manufacturers and other advertisers of dietary supplements such as distributors, retailers, and endorsers, have adequate substantiation that the claims...

read more